Intrinsic caspase-8 activation mediates sensitization of erlotinib-resistant tumor cells to erlotinib/cell-cycle inhibitors combination treatment
出版年份 2012 全文链接
标题
Intrinsic caspase-8 activation mediates sensitization of erlotinib-resistant tumor cells to erlotinib/cell-cycle inhibitors combination treatment
作者
关键词
-
出版物
Cell Death & Disease
Volume 3, Issue 10, Pages e415-e415
出版商
Springer Nature
发表日期
2012-10-25
DOI
10.1038/cddis.2012.155
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Sequential Application of Anticancer Drugs Enhances Cell Death by Rewiring Apoptotic Signaling Networks
- (2012) Michael J. Lee et al. CELL
- The PIDDosome, DNA-damage-induced apoptosis and beyond
- (2011) S Janssens et al. CELL DEATH AND DIFFERENTIATION
- cIAPs Block Ripoptosome Formation, a RIP1/Caspase-8 Containing Intracellular Cell Death Complex Differentially Regulated by cFLIP Isoforms
- (2011) Maria Feoktistova et al. MOLECULAR CELL
- The Ripoptosome, a Signaling Platform that Assembles in Response to Genotoxic Stress and Loss of IAPs
- (2011) Tencho Tenev et al. MOLECULAR CELL
- Treatment of HER2-positive breast cancer: current status and future perspectives
- (2011) Carlos L. Arteaga et al. Nature Reviews Clinical Oncology
- Cetuximab-Associated Elongation of the Eyelashes
- (2010) Philip R. Cohen et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Bcl-2 proteins and mitochondria—Specificity in membrane targeting for death
- (2010) Jennefer Lindsay et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Synergistic Antitumor Activity of Sorafenib in Combination with Epidermal Growth Factor Receptor Inhibitors in Colorectal and Lung Cancer Cells
- (2010) E. Martinelli et al. CLINICAL CANCER RESEARCH
- Focus on histone variant H2AX: To be or not to be
- (2010) Jingsong Yuan et al. FEBS LETTERS
- Synergistic interaction between trastuzumab and EGFR/HER-2 tyrosine kinase inhibitors in HER-2 positive breast cancer cells
- (2010) Norma O’Donovan et al. INVESTIGATIONAL NEW DRUGS
- New strategies to overcome limitations of reversible EGFR tyrosine kinase inhibitor therapy in non-small cell lung cancer
- (2010) Robert C. Doebele et al. LUNG CANCER
- EGFR signaling in breast cancer: Bad to the bone
- (2010) John Foley et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Efficacy and safety of erlotinib in patients with locally advanced or metastatic breast cancer
- (2008) Maura N. Dickler et al. BREAST CANCER RESEARCH AND TREATMENT
- MCF-7 breast carcinoma cells do not express caspase-3
- (2008) Reiner U. Jänicke BREAST CANCER RESEARCH AND TREATMENT
- TNF-α Induces Two Distinct Caspase-8 Activation Pathways
- (2008) Lai Wang et al. CELL
- Identification of a Molecular Signaling Network that Regulates a Cellular Necrotic Cell Death Pathway
- (2008) Junichi Hitomi et al. CELL
- Synergistic Inhibition of ErbB Signaling by Combined Treatment with Seliciclib and ErbB-Targeting Agents
- (2008) I. N. Fleming et al. CLINICAL CANCER RESEARCH
- Modulation of Cellular Apoptosis with Apoptotic Protease-Activating Factor 1 (Apaf-1) Inhibitors
- (2008) L. Mondragón et al. JOURNAL OF MEDICINAL CHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More